TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.
Saved in:
| Title: | TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors. |
|---|---|
| Authors: | Gymnopoulos M; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Betancourt O; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Blot V; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Fujita R; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Galvan D; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Lieuw V; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Nguyen S; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Snedden J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Stewart C; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Villicana J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Wojciak J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Wong E; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Pardo R; Spirogen, a member of the AstraZeneca Group, London, UK., Patel N; Spirogen, a member of the AstraZeneca Group, London, UK., D'Hooge F; Spirogen, a member of the AstraZeneca Group, London, UK., Vijayakrishnan B; Spirogen, a member of the AstraZeneca Group, London, UK., Barry C; Spirogen, a member of the AstraZeneca Group, London, UK., Hartley JA; Spirogen, a member of the AstraZeneca Group, London, UK., Howard PW; Spirogen, a member of the AstraZeneca Group, London, UK., Newman R; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Coronella J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA. |
| Source: | Molecular oncology [Mol Oncol] 2020 Jan; Vol. 14 (1), pp. 54-68. Date of Electronic Publication: 2019 Dec 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31736230 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gymnopoulos+M%22">Gymnopoulos M</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Betancourt+O%22">Betancourt O</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Blot+V%22">Blot V</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fujita+R%22">Fujita R</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Galvan+D%22">Galvan D</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lieuw+V%22">Lieuw V</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+S%22">Nguyen S</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Snedden+J%22">Snedden J</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+C%22">Stewart C</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Villicana+J%22">Villicana J</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wojciak+J%22">Wojciak J</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wong+E%22">Wong E</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pardo+R%22">Pardo R</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22D'Hooge+F%22">D'Hooge F</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Vijayakrishnan+B%22">Vijayakrishnan B</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Barry+C%22">Barry C</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Hartley+JA%22">Hartley JA</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Howard+PW%22">Howard PW</searchLink>; Spirogen, a member of the AstraZeneca Group, London, UK.<br /><searchLink fieldCode="AU" term="%22Newman+R%22">Newman R</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Coronella+J%22">Coronella J</searchLink>; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2020 Jan; Vol. 14 (1), pp. 54-68. <i>Date of Electronic Publication: </i>2019 Dec 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31736230 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.12600 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 54 Titles: – TitleFull: TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gymnopoulos M – PersonEntity: Name: NameFull: Betancourt O – PersonEntity: Name: NameFull: Blot V – PersonEntity: Name: NameFull: Fujita R – PersonEntity: Name: NameFull: Galvan D – PersonEntity: Name: NameFull: Lieuw V – PersonEntity: Name: NameFull: Nguyen S – PersonEntity: Name: NameFull: Snedden J – PersonEntity: Name: NameFull: Stewart C – PersonEntity: Name: NameFull: Villicana J – PersonEntity: Name: NameFull: Wojciak J – PersonEntity: Name: NameFull: Wong E – PersonEntity: Name: NameFull: Pardo R – PersonEntity: Name: NameFull: Patel N – PersonEntity: Name: NameFull: D'Hooge F – PersonEntity: Name: NameFull: Vijayakrishnan B – PersonEntity: Name: NameFull: Barry C – PersonEntity: Name: NameFull: Hartley JA – PersonEntity: Name: NameFull: Howard PW – PersonEntity: Name: NameFull: Newman R – PersonEntity: Name: NameFull: Coronella J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2020 Jan Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1878-0261 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |